Insulet | PODD - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 23.5B 1.02B 2026-09
Align Technology USD 2.73B 63.03M 2026-09
AtriCure USD 363.39M 17.86M 2026-09
Baxter International USD 6.83B 163M 2026-09
Becton, Dickinson and Co. USD 8.32B 178M 2026-09
Boston Scientific USD 8.16B 192M 2026-09
Cardinal Health USD 40.99B 2.24B 2026-09
Cooper Companies USD 2.28B 18.3M 2026-06
Dexcom USD 3.92B 170.6M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Globus Medical USD 2.18B 33.55M 2026-09
ICU Medical USD 1.22B 8.96M 2026-09
Inogen USD 203.72M 594K 2025-09
Insulet USD 2.04B 192.4M 2026-09
Integra LifeSciences USD 1.19B 1.54M 2026-09
J&J USD 56.35B 3.42B 2026-09
Medtronic USD 24.39B 397M 2026-06
Merit Medical Systems USD 1.2B 86.58M 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Solventum Corp USD 3.69B 49M 2026-09
Stryker USD 14.18B 235M 2026-09
Tandem Diabetes Care USD 820.72M 16.08M 2026-09
Teleflex USD 1.84B 31.2M 2026-09
West Pharmaceutical Services USD 1.82B 9M 2026-09
Zimmer Biomet Holdings USD 5.13B 32.3M 2026-09